Biotechnology
The Biotechnology industry has a total of 595 stocks, with a combined market cap of $1.39 trillion and total revenue of $115.78 billion.
Market Cap
1.39T
Revenue
115.78B
Profits
-39.71B
PE Ratio
n/a
Profit Margin
-34.29%
Dividend Yield
0.04%
594 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 138.91B | 1.44% | 1,074,796 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 83.28B | 0.90% | 786,840 | 15.53B |
| 3 | ARGX | argenx SE | 65.85B | 0.16% | 377,300 | 5.32B |
| 4 | MRNA | Moderna, Inc. | 57.94B | 8.86% | 87,315,627 | 2.23B |
| 5 | RVMD | Revolution Medicines, Inc. | 44.89B | -1.08% | 2,124,325 | - |
| 6 | ONC | BeOne Medicines AG | 42.58B | 1.44% | 252,598 | 6.13B |
| 7 | RPRX | Royalty Pharma plc | 35.25B | 1.21% | 2,325,103 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 31.61B | 3.02% | 1,906,388 | 4.80B |
| 9 | BNTX | BioNTech SE | 29.28B | 5.12% | 2,960,396 | 3.03B |
| 10 | INSM | Insmed Incorporated | 27.47B | 0.55% | 1,124,461 | 1.14B |
| 11 | ROIV | Roivant Sciences Ltd. | 26.22B | -1.47% | 6,185,417 | 7.53M |
| 12 | INCY | Incyte Corporation | 25.91B | 0.46% | 1,367,411 | 5.82B |
| 13 | GMAB | Genmab A/S | 20.06B | 0.12% | 2,535,451 | 4.13B |
| 14 | ASND | Ascendis Pharma A/S | 16.63B | -0.60% | 363,758 | 1.20B |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 16.51B | 2.24% | 516,753 | 4.60B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 15.93B | -1.74% | 1,819,205 | 713.07M |
| 17 | EXEL | Exelixis, Inc. | 13.40B | 0.73% | 1,949,642 | 2.44B |
| 18 | CORT | Corcept Therapeutics Incorporated | 13.22B | 0.99% | 656,311 | 830.81M |
| 19 | BMRN | BioMarin Pharmaceutical Inc. | 12.91B | -1.45% | 1,593,612 | 3.41B |
| 20 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.30B | -0.41% | 1,090,199 | 669.50M |
| 21 | HALO | Halozyme Therapeutics, Inc. | 12.28B | 1.93% | 1,173,961 | 1.66B |
| 22 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.94B | -0.45% | 179,830 | 1.28B |
| 23 | TECH | Bio-Techne Corporation | 11.34B | 0.06% | 3,957,631 | 1.22B |
| 24 | ABVX | ABIVAX Société Anonyme | 11.12B | -2.75% | 988,407 | 5.67M |
| 25 | AXSM | Axsome Therapeutics, Inc. | 10.88B | -0.12% | 734,780 | 776.57M |
| 26 | CYTK | Cytokinetics, Incorporated | 10.68B | -0.44% | 1,521,131 | 67.67M |
| 27 | SMMT | Summit Therapeutics Inc. | 10.50B | 5.87% | 7,074,307 | - |
| 28 | PRAX | Praxis Precision Medicines, Inc. | 10.50B | 3.12% | 413,316 | 7.46M |
| 29 | KRYS | Krystal Biotech, Inc. | 10.26B | 2.84% | 407,782 | 440.48M |
| 30 | APGE | Apogee Therapeutics, Inc. | 10.16B | - | 948,282 | - |
| 31 | PTGX | Protagonist Therapeutics, Inc. | 9.99B | 2.41% | 402,517 | 281.99M |
| 32 | KYMR | Kymera Therapeutics, Inc. | 9.96B | -1.40% | 503,426 | 105.00M |
| 33 | IONS | Ionis Pharmaceuticals, Inc. | 9.93B | 1.67% | 2,723,889 | 874.09M |
| 34 | SYRE | Spyre Therapeutics, Inc. | 9.39B | -1.21% | 1,014,893 | - |
| 35 | PCVX | Vaxcyte, Inc. | 9.32B | 2.09% | 1,141,427 | - |
| 36 | IMVT | Immunovant, Inc. | 9.16B | 0.05% | 846,584 | - |
| 37 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.98B | - | 2,016,045 | 42.16M |
| 38 | IBRX | ImmunityBio, Inc. | 8.26B | -0.64% | 7,619,706 | 165.79M |
| 39 | TGTX | TG Therapeutics, Inc. | 7.70B | 7.34% | 5,558,340 | 799.54M |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.57B | 0.99% | 523,136 | 239.92M |
| 41 | CAI | Caris Life Sciences, Inc. | 7.42B | 6.88% | 6,389,323 | 989.61M |
| 42 | ORKA | Oruka Therapeutics, Inc. | 7.15B | 2.96% | 935,776 | - |
| 43 | CGON | CG Oncology, Inc. | 7.07B | 2.83% | 701,750 | 6.23M |
| 44 | SRRK | Scholar Rock Holding Corporation | 6.88B | 2.26% | 1,156,414 | - |
| 45 | BLTE | Belite Bio, Inc | 6.49B | -0.54% | 111,224 | - |
| 46 | COGT | Cogent Biosciences, Inc. | 6.38B | 4.02% | 2,515,728 | - |
| 47 | MIRM | Mirum Pharmaceuticals, Inc. | 6.25B | -0.78% | 731,681 | 618.07M |
| 48 | DNTH | Dianthus Therapeutics, Inc. | 6.21B | 1.45% | 730,865 | 1.90M |
| 49 | TVTX | Travere Therapeutics, Inc. | 6.19B | 1.94% | 1,624,893 | 591.33M |
| 50 | ERAS | Erasca, Inc. | 6.17B | 3.22% | 2,445,399 | - |
| 51 | DFTX | Definium Therapeutics, Inc. | 6.03B | -1.08% | 1,355,030 | - |
| 52 | XENE | Xenon Pharmaceuticals Inc. | 5.88B | 1.74% | 792,928 | 7.50M |
| 53 | PTCT | PTC Therapeutics, Inc. | 5.83B | -0.99% | 674,736 | 1.01B |
| 54 | CRSP | CRISPR Therapeutics AG | 5.75B | 2.37% | 2,453,842 | 13.39M |
| 55 | LGND | Ligand Pharmaceuticals Incorporated | 5.71B | -0.38% | 152,535 | 290.54M |
| 56 | ACAD | ACADIA Pharmaceuticals Inc. | 5.08B | 1.58% | 1,093,500 | 1.14B |
| 57 | DYN | Dyne Therapeutics, Inc. | 4.87B | 0.46% | 1,181,539 | - |
| 58 | PBLS | Parabilis Medicines, Inc. | 4.86B | -0.56% | 354,579 | 148.00K |
| 59 | EWTX | Edgewise Therapeutics, Inc. | 4.80B | 2.06% | 1,249,637 | - |
| 60 | CELC | Celcuity Inc. | 4.58B | 3.27% | 889,294 | - |
| 61 | ELVN | Enliven Therapeutics, Inc. | 4.38B | 1.53% | 596,337 | - |
| 62 | MANE | Veradermics, Incorporated | 4.30B | -2.37% | 393,616 | - |
| 63 | RLAY | Relay Therapeutics, Inc. | 4.26B | -1.32% | 2,965,763 | 10.35M |
| 64 | LEGN | Legend Biotech Corporation | 4.23B | 2.63% | 1,424,309 | 1.27B |
| 65 | TNGX | Tango Therapeutics, Inc. | 4.03B | 1.57% | 2,489,239 | 53.81M |
| 66 | DNLI | Denali Therapeutics Inc. | 3.98B | -0.12% | 680,924 | 3.60M |
| 67 | VKTX | Viking Therapeutics, Inc. | 3.95B | -1.37% | 1,502,761 | - |
| 68 | RCUS | Arcus Biosciences, Inc. | 3.86B | 2.78% | 1,055,171 | 117.00M |
| 69 | IDYA | IDEAYA Biosciences, Inc. | 3.83B | 1.43% | 860,569 | 234.13M |
| 70 | TLX | Telix Pharmaceuticals Limited | 3.80B | -8.78% | 299,600 | 890.79M |
| 71 | IOVA | Iovance Biotherapeutics, Inc. | 3.76B | -7.79% | 27,808,765 | 324.97M |
| 72 | ABCL | AbCellera Biologics Inc. | 3.67B | -2.16% | 4,553,044 | 66.17M |
| 73 | GPCR | Structure Therapeutics Inc. | 3.50B | -2.83% | 592,278 | - |
| 74 | QURE | uniQure N.V. | 3.36B | -1.06% | 673,833 | 18.67M |
| 75 | NAMS | NewAmsterdam Pharma Company N.V. | 3.33B | 0.32% | 525,427 | 7.12M |
| 76 | IMNM | Immunome, Inc. | 3.24B | 1.57% | 848,793 | 4.02M |
| 77 | MBX | MBX Biosciences, Inc. | 3.19B | -0.03% | 466,639 | - |
| 78 | TARS | Tarsus Pharmaceuticals, Inc. | 3.19B | 1.69% | 636,334 | 606.33M |
| 79 | CLDX | Celldex Therapeutics, Inc. | 3.17B | 1.10% | 837,587 | 158.00K |
| 80 | ARQT | Arcutis Biotherapeutics, Inc. | 3.15B | -1.07% | 2,159,269 | 463.98M |
| 81 | ALMS | Alumis Inc. | 3.13B | 5.73% | 934,802 | 7.40M |
| 82 | SLS | SELLAS Life Sciences Group, Inc. | 3.12B | 15.37% | 15,242,029 | - |
| 83 | IRON | Disc Medicine, Inc. | 3.06B | 1.23% | 370,352 | - |
| 84 | BEAM | Beam Therapeutics Inc. | 2.97B | 4.83% | 2,460,847 | 156.04M |
| 85 | ZLAB | Zai Lab Limited | 2.92B | -0.04% | 1,002,166 | 449.61M |
| 86 | NRIX | Nurix Therapeutics, Inc. | 2.77B | -1.22% | 1,485,856 | 36.77M |
| 87 | VRDN | Viridian Therapeutics, Inc. | 2.75B | -0.86% | 906,283 | 71.13M |
| 88 | ATAI | AtaiBeckley Inc. | 2.74B | -0.54% | 4,307,465 | 4.47M |
| 89 | PGEN | Precigen, Inc. | 2.58B | -3.23% | 4,406,123 | 85.72M |
| 90 | TRVI | Trevi Therapeutics, Inc. | 2.56B | -1.59% | 1,136,241 | - |
| 91 | PHVS | Pharvaris N.V. | 2.55B | -0.33% | 515,366 | - |
| 92 | RARE | Ultragenyx Pharmaceutical Inc. | 2.54B | 2.01% | 2,396,765 | 717.00M |
| 93 | NKTR | Nektar Therapeutics | 2.53B | -0.68% | 614,080 | 54.59M |
| 94 | OCUL | Ocular Therapeutix, Inc. | 2.43B | -0.09% | 3,051,266 | 52.06M |
| 95 | NUVB | Nuvation Bio Inc. | 2.43B | 1.46% | 6,044,564 | 169.90M |
| 96 | KOD | Kodiak Sciences Inc. | 2.40B | -3.79% | 508,992 | - |
| 97 | VERA | Vera Therapeutics, Inc. | 2.33B | 3.25% | 1,288,427 | - |
| 98 | RAPP | Rapport Therapeutics, Inc. | 2.31B | 0.82% | 140,868 | 20.00M |
| 99 | COAG | Hemab Therapeutics Holdings, Inc. | 2.30B | 1.99% | 391,756 | - |
| 100 | URGN | UroGen Pharma Ltd. | 2.29B | 0.13% | 755,445 | 188.73M |
| 101 | MLYS | Mineralys Therapeutics, Inc. | 2.27B | -0.39% | 699,828 | - |
| 102 | NBTX | Nanobiotix S.A. | 2.25B | -0.30% | 74,312 | 38.27M |
| 103 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.24B | 4.22% | 9,392,155 | 208.78M |
| 104 | KLRA | Kailera Therapeutics, Inc. | 2.23B | -1.66% | 436,806 | - |
| 105 | HRMY | Harmony Biosciences Holdings, Inc. | 2.22B | 0.21% | 380,014 | 959.90M |
| 106 | AUPH | Aurinia Pharmaceuticals Inc. | 2.22B | -3.59% | 1,248,726 | 311.51M |
| 107 | ADMA | ADMA Biologics, Inc. | 2.20B | 0.82% | 1,477,002 | 512.28M |
| 108 | MESO | Mesoblast Limited | 2.20B | -2.47% | 164,709 | 65.38M |
| 109 | VCEL | Vericel Corporation | 2.19B | 1.35% | 647,127 | 306.30M |
| 110 | ZBIO | Zenas BioPharma, Inc. | 2.10B | 2.12% | 808,682 | 1.00M |
| 111 | BHVN | Biohaven Ltd. | 2.09B | 2.59% | 2,085,853 | - |
| 112 | STOK | Stoke Therapeutics, Inc. | 2.08B | 2.83% | 1,274,382 | 27.59M |
| 113 | GENB | Generate Biomedicines, Inc. | 2.07B | 0.81% | 831,836 | 26.48M |
| 114 | XNCR | Xencor, Inc. | 2.07B | 2.96% | 753,067 | 104.97M |
| 115 | PVLA | Palvella Therapeutics, Inc. | 2.05B | -0.38% | 161,866 | - |
| 116 | ZYME | Zymeworks Inc. | 2.03B | 7.90% | 836,381 | 37.13M |
| 117 | SRPT | Sarepta Therapeutics, Inc. | 1.98B | -2.24% | 1,674,554 | 1.97B |
| 118 | TSHA | Taysha Gene Therapies, Inc. | 1.98B | -0.33% | 2,830,960 | 5.49M |
| 119 | AGIO | Agios Pharmaceuticals, Inc. | 1.98B | -1.61% | 577,551 | 98.34M |
| 120 | KARD | Kardigan, Inc. | 1.97B | 3.75% | 159,546 | - |
| 121 | GHRS | GH Research PLC | 1.94B | -1.22% | 141,702 | - |
| 122 | FBRX | Forte Biosciences, Inc. | 1.94B | 0.04% | 2,012,128 | - |
| 123 | DMRA | Damora Therapeutics, Inc. | 1.90B | 1.68% | 159,903 | - |
| 124 | IMCR | Immunocore Holdings plc | 1.90B | 1.65% | 329,451 | 430.78M |
| 125 | LKFT | Lakefront Biotherapeutics NV | 1.89B | 1.87% | 264,375 | 1.13B |
| 126 | RXRX | Recursion Pharmaceuticals, Inc. | 1.88B | 4.79% | 22,898,467 | 54.86M |
| 127 | SEPN | Septerna, Inc. | 1.87B | -1.94% | 289,806 | 98.88M |
| 128 | NTLA | Intellia Therapeutics, Inc. | 1.80B | 3.22% | 3,347,693 | 59.51M |
| 129 | BRVE | Braveheart Bio, Inc. | 1.77B | 0.58% | 130,487 | - |
| 130 | SNDX | Syndax Pharmaceuticals, Inc. | 1.75B | -0.51% | 1,695,906 | 252.25M |
| 131 | FTRE | Fortrea Holdings Inc. | 1.75B | 1.10% | 864,119 | 2.68B |
| 132 | ANAB | AnaptysBio, Inc. | 1.71B | 1.85% | 318,372 | 232.39M |
| 133 | AVLN | Avalyn Pharma Inc. | 1.70B | 3.34% | 159,499 | - |
| 134 | VIR | Vir Biotechnology, Inc. | 1.65B | 6.19% | 1,756,467 | 303.23M |
| 135 | ABSI | Absci Corporation | 1.64B | 2.91% | 2,332,243 | 1.56M |
| 136 | MAZE | Maze Therapeutics, Inc. | 1.63B | 1.73% | 280,573 | 20.00M |
| 137 | BCAX | Bicara Therapeutics Inc. | 1.58B | -2.01% | 496,340 | - |
| 138 | TYRA | Tyra Biosciences, Inc. | 1.55B | 1.40% | 493,596 | - |
| 139 | APMD | Apnimed, Inc. | 1.55B | -1.82% | 246,332 | 120.15M |
| 140 | AAPG | Ascentage Pharma Group International | 1.54B | -1.85% | 1,838 | 94.61M |
| 141 | TRAX | First Tracks Biotherapeutics, Inc. | 1.54B | 2.89% | 527,979 | - |
| 142 | LBRX | LB Pharmaceuticals Inc | 1.54B | 0.83% | 225,825 | - |
| 143 | INBX | Inhibrx Biosciences, Inc. | 1.53B | 4.52% | 220,742 | 1.30M |
| 144 | INVA | Innoviva, Inc. | 1.52B | 0.33% | 499,377 | 440.00M |
| 145 | SLBT | SL Science Holding Limited | 1.51B | -2.21% | 28,476 | 3.27M |
| 146 | NVAX | Novavax, Inc. | 1.47B | 6.18% | 10,448,190 | 413.80M |
| 147 | ORIC | ORIC Pharmaceuticals, Inc. | 1.47B | 2.31% | 970,492 | - |
| 148 | AVBP | ArriVent BioPharma, Inc. | 1.44B | -0.21% | 304,809 | - |
| 149 | SVRA | Savara Inc. | 1.42B | 1.82% | 3,035,363 | - |
| 150 | LTGO | Latigo Biotherapeutics, Inc. | 1.41B | 4.53% | 197,197 | - |
| 151 | CGEM | Cullinan Therapeutics, Inc. | 1.40B | 1.40% | 758,221 | - |
| 152 | OMER | Omeros Corporation | 1.39B | 3.44% | 2,582,553 | 38.42M |
| 153 | REPL | Replimune Group, Inc. | 1.39B | 5.12% | 2,969,262 | - |
| 154 | VOR | Vor Biopharma Inc. | 1.38B | 1.28% | 618,161 | - |
| 155 | DRTS | Alpha Tau Medical Ltd. | 1.38B | 3.90% | 626,150 | - |
| 156 | MGTX | MeiraGTx Holdings plc | 1.38B | -1.38% | 635,483 | 397.50M |
| 157 | JBIO | Jade Biosciences, Inc. | 1.36B | 0.52% | 571,847 | - |
| 158 | ANRO | Alto Neuroscience, Inc. | 1.35B | 0.09% | 291,140 | - |
| 159 | MLTX | MoonLake Immunotherapeutics | 1.34B | -0.69% | 1,351,538 | - |
| 160 | AKTS | Aktis Oncology, Inc. | 1.34B | 0.29% | 226,257 | 10.06M |
| 161 | MNKD | MannKind Corporation | 1.33B | -2.58% | 3,204,974 | 393.63M |
| 162 | SPTX | Seaport Therapeutics, Inc. | 1.30B | 1.12% | 83,149 | - |
| 163 | ODTX | Odyssey Therapeutics, Inc. | 1.26B | 6.97% | 181,208 | 99.00K |
| 164 | IMTX | Immatics N.V. | 1.22B | 4.44% | 611,294 | 47.65M |
| 165 | GLUE | Monte Rosa Therapeutics, Inc. | 1.22B | -3.25% | 969,158 | 28.73M |
| 166 | CRVS | Corvus Pharmaceuticals, Inc. | 1.22B | 0.91% | 473,785 | - |
| 167 | SANA | Sana Biotechnology, Inc. | 1.17B | 4.55% | 2,927,167 | - |
| 168 | IVA | Inventiva S.A. | 1.11B | 0.65% | 461,395 | 7.94M |
| 169 | AVTX | Avalo Therapeutics, Inc. | 1.06B | 0.05% | 569,829 | 59.00K |
| 170 | JANX | Janux Therapeutics, Inc. | 1.06B | 0.64% | 520,030 | 24.00M |
| 171 | KURA | Kura Oncology, Inc. | 1.06B | 1.54% | 2,027,515 | 77.23M |
| 172 | WVE | Wave Life Sciences, Inc. | 1.04B | 0.76% | 2,721,869 | 65.37M |
| 173 | ABUS | Arbutus Biopharma Corporation | 1.03B | 9.22% | 18,070,384 | 181.72M |
| 174 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.02B | 5.50% | 3,194,805 | 41.47M |
| 175 | CADL | Candel Therapeutics, Inc. | 1.00B | 6.32% | 1,339,276 | - |
| 176 | SLDB | Solid Biosciences Inc. | 997.19M | 2.20% | 790,346 | - |
| 177 | CLYM | Climb Bio, Inc. | 992.50M | 1.53% | 957,412 | - |
| 178 | IMMX | Immix Biopharma, Inc. | 977.23M | 3.80% | 1,510,571 | - |
| 179 | GERN | Geron Corporation | 976.56M | -1.94% | 4,433,379 | 204.56M |
| 180 | ARDX | Ardelyx, Inc. | 969.34M | -0.26% | 2,878,948 | 450.89M |
| 181 | ANNX | Annexon, Inc. | 961.17M | -2.12% | 1,429,648 | - |
| 182 | ACRS | Aclaris Therapeutics, Inc. | 943.54M | 1.26% | 2,208,315 | 8.22M |
| 183 | DSGN | Design Therapeutics, Inc. | 938.10M | -3.66% | 551,765 | - |
| 184 | OLMA | Olema Pharmaceuticals, Inc. | 935.35M | -1.93% | 748,501 | - |
| 185 | HELP | Cybin Inc. | 919.83M | 0.96% | 2,165,206 | - |
| 186 | ATTO | Attovia Therapeutics, Inc. | 895.00M | 2.92% | 362,155 | 1.35M |
| 187 | SGP | SpyGlass Pharma, Inc. | 886.71M | 1.07% | 52,271 | - |
| 188 | TBPH | Theravance Biopharma, Inc. | 883.14M | 0.35% | 739,343 | 104.31M |
| 189 | ANL | Adlai Nortye Ltd. | 882.25M | -0.15% | 103,050 | 18.06M |
| 190 | FDMT | 4D Molecular Therapeutics, Inc. | 874.52M | -1.68% | 921,167 | 92.01M |
| 191 | DBVT | DBV Technologies S.A. | 862.94M | 2.18% | 124,583 | 5.04M |
| 192 | OBX | Obsidian Therapeutics, Inc. | 862.19M | -1.44% | 1,449,276 | - |
| 193 | RIGL | Rigel Pharmaceuticals, Inc. | 857.22M | 1.41% | 322,086 | 276.79M |
| 194 | PHAR | Pharming Group N.V. | 839.49M | 1.46% | 11,004 | 366.48M |
| 195 | FTH | Faeth Therapeutics, Inc. | 826.89M | -0.31% | 433,893 | - |
| 196 | ACHV | Achieve Life Sciences, Inc. | 822.19M | -0.37% | 1,063,954 | - |
| 197 | AURA | Aura Biosciences, Inc. | 808.90M | 0.39% | 500,879 | - |
| 198 | OCS | Oculis Holding AG | 807.76M | -0.42% | 76,462 | 1.45M |
| 199 | SLN | Silence Therapeutics plc | 798.98M | 0.76% | 740,545 | 615.00K |
| 200 | DRUG | Bright Minds Biosciences Inc. | 774.85M | -1.45% | 165,838 | - |
| 201 | NGNE | Neurogene Inc. | 773.04M | 1.68% | 346,579 | 925.00K |
| 202 | NVCT | Nuvectis Pharma, Inc. | 767.62M | 0.90% | 196,956 | - |
| 203 | STTK | Shattuck Labs, Inc. | 755.74M | 3.86% | 475,542 | 1.00M |
| 204 | TECX | Tectonic Therapeutic, Inc. | 735.64M | 4.38% | 188,531 | - |
| 205 | CBIO | Crescent Biopharma, Inc. | 734.04M | 5.67% | 218,388 | 11.88M |
| 206 | GYRE | Gyre Therapeutics, Inc. | 732.69M | -1.57% | 65,998 | 109.82M |
| 207 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 727.98M | - | 171,565 | - |
| 208 | MNPR | Monopar Therapeutics Inc. | 723.04M | -2.85% | 176,419 | - |
| 209 | ALLO | Allogene Therapeutics, Inc. | 722.08M | -0.48% | 4,372,292 | 4.64M |
| 210 | CTMX | CytomX Therapeutics, Inc. | 714.71M | -0.30% | 2,894,667 | 18.30M |
| 211 | RGNX | REGENXBIO Inc. | 707.66M | -3.07% | 1,007,023 | 174.48M |
| 212 | ZVRA | Zevra Therapeutics, Inc. | 704.89M | -0.17% | 704,111 | 136.07M |
| 213 | PHAT | Phathom Pharmaceuticals, Inc. | 704.54M | 3.14% | 979,410 | 239.66M |
| 214 | ASMB | Assembly Biosciences, Inc. | 700.00M | 2.54% | 341,472 | 74.85M |
| 215 | PRLD | Prelude Therapeutics Incorporated | 682.86M | 2.00% | 519,206 | 22.42M |
| 216 | VALN | Valneva SE | 656.66M | 2.05% | 21,593 | 163.30M |
| 217 | AGMB | AgomAb Therapeutics NV | 652.54M | -1.34% | 68,360 | - |
| 218 | CTNM | Contineum Therapeutics, Inc. | 646.71M | 7.30% | 353,837 | - |
| 219 | SCTX | Scribe Therapeutics Inc. | 643.84M | 3.96% | 179,389 | 36.28M |
| 220 | AUTL | Autolus Therapeutics plc | 641.45M | -2.03% | 2,410,590 | 117.39M |
| 221 | CRMD | CorMedix Inc. | 639.14M | -0.36% | 1,496,583 | 462.25M |
| 222 | SGMT | Sagimet Biosciences Inc. | 637.13M | 0.69% | 1,022,514 | - |
| 223 | MDXG | MiMedx Group, Inc. | 631.14M | 0.70% | 897,111 | 355.17M |
| 224 | OABI | OmniAb, Inc. | 629.54M | 0.70% | 1,852,682 | 38.46M |
| 225 | VSTM | Verastem, Inc. | 623.98M | 1.03% | 996,115 | 87.53M |
| 226 | EIKN | Eikon Therapeutics, Inc. | 616.94M | 5.95% | 532,767 | - |
| 227 | ARVN | Arvinas, Inc. | 612.34M | 3.71% | 951,751 | 316.70M |
| 228 | ALT | Altimmune, Inc. | 604.95M | 5.42% | 6,156,701 | 31.00K |
| 229 | PRME | Prime Medicine, Inc. | 603.10M | 4.63% | 3,602,651 | 4.07M |
| 230 | ZURA | Zura Bio Limited | 560.60M | 1.74% | 724,891 | - |
| 231 | ENTX | Entera Bio Ltd. | 559.25M | 0.31% | 441,297 | 42.00K |
| 232 | SPRY | ARS Pharmaceuticals, Inc. | 547.46M | -0.09% | 1,267,918 | 116.93M |
| 233 | OVID | Ovid Therapeutics Inc. | 546.83M | 2.19% | 1,331,894 | 1.58M |
| 234 | ARTV | Artiva Biotherapeutics, Inc. | 534.37M | -1.89% | 199,277 | 251.00K |
| 235 | RZLT | Rezolute, Inc. | 531.74M | 9.23% | 6,500,573 | - |
| 236 | CABA | Cabaletta Bio, Inc. | 530.68M | -1.88% | 4,404,533 | - |
| 237 | KYTX | Kyverna Therapeutics, Inc. | 520.72M | 3.57% | 663,596 | - |
| 238 | MPLT | MapLight Therapeutics, Inc. | 519.90M | -0.18% | 435,204 | - |
| 239 | EVMN | Evommune, Inc. | 508.82M | 3.32% | 326,549 | 10.00M |
| 240 | BLSM | BlossomHill Therapeutics, Inc. | 501.94M | 3.67% | 111,382 | - |
| 241 | DNA | Ginkgo Bioworks Holdings, Inc. | 498.32M | 6.32% | 1,436,835 | 132.42M |
| 242 | RLMD | Relmada Therapeutics, Inc. | 493.88M | -0.22% | 985,171 | - |
| 243 | CCCC | C4 Therapeutics, Inc. | 492.10M | -0.74% | 1,161,742 | 35.04M |
| 244 | PROK | ProKidney Corp. | 486.74M | 13.38% | 1,725,754 | 818.00K |
| 245 | PRTA | Prothena Corporation plc | 485.13M | 4.65% | 376,044 | 54.53M |
| 246 | EDIT | Editas Medicine, Inc. | 477.63M | 5.78% | 2,116,417 | 47.01M |
| 247 | PBYI | Puma Biotechnology, Inc. | 476.97M | 1.43% | 333,531 | 231.24M |
| 248 | QTTB | Q32 Bio Inc. | 475.42M | 0.69% | 341,504 | 53.74M |
| 249 | OCGN | Ocugen, Inc. | 471.36M | - | 2,446,629 | 4.58M |
| 250 | BNTC | Benitec Biopharma Inc. | 463.10M | 3.61% | 160,139 | - |
| 251 | EYPT | EyePoint, Inc. | 458.65M | -1.48% | 8,186,371 | 2.79M |
| 252 | EPRX | Eupraxia Pharmaceuticals Inc. | 445.15M | -0.44% | 297,905 | - |
| 253 | LRMR | Larimar Therapeutics, Inc. | 436.32M | 0.48% | 699,419 | - |
| 254 | AVIR | Atea Pharmaceuticals, Inc. | 435.51M | 1.31% | 209,892 | - |
| 255 | IKT | Inhibikase Therapeutics, Inc. | 435.16M | 1.70% | 309,308 | 1.00 |
| 256 | CMPX | Compass Therapeutics, Inc. | 432.21M | 1.69% | 2,032,331 | 850.00K |
| 257 | FHTX | Foghorn Therapeutics Inc. | 419.85M | 0.86% | 536,547 | 36.74M |
| 258 | VTVT | vTv Therapeutics Inc. | 413.19M | 0.53% | 26,673 | 36.84M |
| 259 | VOGX | Vogenx, Inc. | 410.85M | 24.82% | 428,732 | - |
| 260 | XFOR | X4 Pharmaceuticals, Inc. | 400.55M | 0.25% | 1,219,578 | 15.85M |
| 261 | LXEO | Lexeo Therapeutics, Inc. | 400.37M | -3.56% | 509,586 | - |
| 262 | FENC | Fennec Pharmaceuticals Inc. | 395.91M | -0.53% | 194,550 | 59.22M |
| 263 | ENTA | Enanta Pharmaceuticals, Inc. | 392.32M | 2.59% | 335,245 | 65.26M |
| 264 | RCKT | Rocket Pharmaceuticals, Inc. | 385.31M | 0.86% | 939,751 | - |
| 265 | ARCT | Arcturus Therapeutics Holdings Inc. | 382.29M | 22.38% | 2,856,256 | 29.37M |
| 266 | UPB | Upstream Bio, Inc. | 381.75M | 1.75% | 434,240 | 3.16M |
| 267 | LYEL | Lyell Immunopharma, Inc. | 380.56M | 1.17% | 104,914 | 27.00K |
| 268 | CUVL | Clinuvel Pharmaceuticals Limited | 376.65M | - | 205 | 64.24M |
| 269 | IPSC | Century Therapeutics, Inc. | 374.83M | 2.48% | 330,590 | 109.16M |
| 270 | GALT | Galectin Therapeutics Inc. | 371.13M | 3.08% | 174,888 | - |
| 271 | PALI | Palisade Bio, Inc. | 365.97M | 1.94% | 1,070,498 | 500.00K |
| 272 | CAPR | Capricor Therapeutics, Inc. | 365.69M | -8.04% | 8,360,730 | 11.13M |
| 273 | AGEN | Agenus Inc. | 364.22M | 8.01% | 1,517,226 | 132.69M |
| 274 | ZNTL | Zentalis Pharmaceuticals, Inc. | 362.12M | -0.39% | 741,800 | 26.87M |
| 275 | DMAC | DiaMedica Therapeutics Inc. | 351.60M | - | 77,573 | - |
| 276 | STRO | Sutro Biopharma, Inc. | 348.87M | -0.57% | 194,668 | 45.70M |
| 277 | ABEO | Abeona Therapeutics Inc. | 348.25M | 2.18% | 894,799 | 25.52M |
| 278 | SABS | SAB Biotherapeutics, Inc. | 343.93M | 2.16% | 195,668 | 114.70K |
| 279 | IMRX | Immuneering Corporation | 342.90M | 0.95% | 445,715 | - |
| 280 | IRD | Opus Genetics, Inc. | 336.94M | -1.70% | 1,051,223 | 9.86M |
| 281 | PRQR | ProQR Therapeutics N.V. | 330.22M | 3.08% | 725,822 | 21.05M |
| 282 | YDES | YD Bio Limited | 329.80M | -2.01% | 36,003 | 510.36K |
| 283 | VCRE | Vicore Pharma Holding AB (publ) | 327.03M | 4.17% | 4,726 | 412.09K |
| 284 | OBIO | Orchestra BioMed Holdings, Inc. | 322.16M | -1.29% | 276,631 | 31.98M |
| 285 | VNDA | Vanda Pharmaceuticals Inc. | 319.24M | -1.86% | 656,682 | 215.72M |
| 286 | IFRX | InflaRx N.V. | 309.47M | 3.96% | 419,890 | -11.54K |
| 287 | NMRA | Neumora Therapeutics, Inc. | 306.27M | 7.59% | 499,105 | - |
| 288 | BCYC | Bicycle Therapeutics plc | 305.87M | 3.07% | 480,740 | 61.21M |
| 289 | RNAC | Cartesian Therapeutics, Inc. | 303.76M | -1.86% | 163,850 | 1.48M |
| 290 | AVXL | Anavex Life Sciences Corp. | 300.26M | 3.51% | 480,485 | - |
| 291 | IVVD | Invivyd, Inc. | 293.73M | 4.81% | 5,425,688 | 58.37M |
| 292 | FULC | Fulcrum Therapeutics, Inc. | 292.22M | -0.52% | 1,512,556 | 80.00M |
| 293 | ACIU | AC Immune SA | 288.34M | 9.85% | 441,967 | 21.67M |
| 294 | ALXO | ALX Oncology Holdings Inc. | 282.09M | 2.51% | 410,847 | - |
| 295 | SRZN | Surrozen, Inc. | 281.97M | 2.09% | 149,722 | 11.51M |
| 296 | TTRX | Turn Therapeutics Inc. | 281.79M | -0.84% | 22,224 | - |
| 297 | CAMP | Camp4 Therapeutics Corporation | 281.13M | 0.45% | 126,862 | 4.22M |
| 298 | ELDN | Eledon Pharmaceuticals, Inc. | 280.63M | -1.99% | 743,904 | - |
| 299 | FATE | Fate Therapeutics, Inc. | 279.18M | -4.90% | 1,697,067 | 6.49M |
| 300 | LCTX | Lineage Cell Therapeutics, Inc. | 273.14M | - | 716,424 | 13.08M |
| 301 | TRDA | Entrada Therapeutics, Inc. | 272.95M | -0.39% | 141,015 | 4.69M |
| 302 | ADAG | Adagene Inc. | 269.92M | -1.96% | 61,306 | 9.29M |
| 303 | WHWK | Whitehawk Therapeutics, Inc. | 269.65M | -2.07% | 226,165 | 7.15M |
| 304 | ALEC | Alector, Inc. | 263.51M | 4.42% | 728,094 | 13.86M |
| 305 | MGNX | MacroGenics, Inc. | 261.17M | 0.74% | 271,461 | 175.14M |
| 306 | PYXS | Pyxis Oncology, Inc. | 256.90M | -1.28% | 682,275 | 11.04M |
| 307 | NAGE | Niagen Bioscience, Inc. | 254.53M | 1.90% | 370,265 | 129.08M |
| 308 | SLGL | Sol-Gel Technologies Ltd. | 254.10M | -0.98% | 33,315 | 1.80M |
| 309 | CGEN | Compugen Ltd. | 247.70M | -1.32% | 447,159 | 74.00M |
| 310 | GLSI | Greenwich LifeSciences, Inc. | 244.69M | 8.88% | 176,694 | - |
| 311 | DTIL | Precision BioSciences, Inc. | 244.27M | 1.49% | 305,178 | 45.06M |
| 312 | CLLS | Cellectis S.A. | 243.57M | -1.87% | 26,655 | 63.82M |
| 313 | SION | Sionna Therapeutics, Inc. | 239.17M | -4.17% | 1,937,731 | - |
| 314 | CNXU | Conexeu Sciences Inc. | 237.88M | -5.73% | 403,557 | - |
| 315 | NBP | NovaBridge Biosciences | 231.30M | 4.71% | 443,025 | - |
| 316 | NERV | Minerva Neurosciences, Inc. | 231.10M | 1.04% | 106,449 | - |
| 317 | ABOS | Acumen Pharmaceuticals, Inc. | 228.52M | -0.94% | 716,023 | - |
| 318 | TARA | Protara Therapeutics, Inc. | 227.52M | -1.28% | 238,375 | - |
| 319 | RNA | Atrium Therapeutics, Inc. | 225.79M | -2.08% | 180,677 | 35.84M |
| 320 | IMUX | Immunic, Inc. | 225.13M | 2.48% | 147,662 | - |
| 321 | CHRS | Coherus Oncology, Inc. | 219.39M | 7.58% | 1,567,374 | 50.94M |
| 322 | ANTX | AN2 Therapeutics, Inc. | 219.25M | 0.35% | 225,449 | - |
| 323 | KROS | Keros Therapeutics, Inc. | 218.69M | 0.73% | 157,507 | 15.01M |
| 324 | PEPG | PepGen Inc. | 217.47M | 3.46% | 671,837 | - |
| 325 | TNXP | Tonix Pharmaceuticals Holding Corp. | 215.25M | 1.29% | 369,261 | 29.10M |
| 326 | ACOG | Alpha Cognition Inc. | 212.33M | 2.63% | 294,448 | 15.26M |
| 327 | IPHA | Innate Pharma S.A. | 209.20M | 8.13% | 44,354 | 10.57M |
| 328 | VYGR | Voyager Therapeutics, Inc. | 208.88M | 2.11% | 424,426 | 34.46M |
| 329 | MSLE | Satellos Bioscience Inc. | 208.17M | -1.77% | 19,055 | - |
| 330 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 200.76M | 5.49% | 603,409 | - |
| 331 | ORMP | Oramed Pharmaceuticals Inc. | 200.08M | 0.42% | 126,128 | 2.00M |
| 332 | NGEN | NervGen Pharma Corp. | 199.99M | 5.68% | 541,978 | - |
| 333 | KRRO | Korro Bio, Inc. | 194.08M | 1.70% | 45,698 | 2.38M |
| 334 | PLX | Protalix BioTherapeutics, Inc. | 191.76M | - | 648,550 | 80.62M |
| 335 | NKTX | Nkarta, Inc. | 190.52M | 7.69% | 1,109,091 | - |
| 336 | ARMP | Armata Pharmaceuticals, Inc. | 189.63M | 15.38% | 111,488 | 5.54M |
| 337 | CDXS | Codexis, Inc. | 182.87M | 5.70% | 1,257,974 | 77.68M |
| 338 | HUMA | Humacyte, Inc. | 178.40M | -5.75% | 9,366,430 | 2.12M |
| 339 | CRBU | Caribou Biosciences, Inc. | 177.96M | 3.11% | 1,151,057 | 10.04M |
| 340 | CNTN | Canton Strategic Holdings, Inc. | 174.50M | -0.90% | 744,695 | 1.50M |
| 341 | INDP | Indaptus Therapeutics, Inc. | 171.88M | -6.52% | 1,138,283 | - |
| 342 | MDWD | MediWound Ltd. | 170.54M | 0.69% | 79,831 | 11.86M |
| 343 | MOLN | Molecular Partners AG | 163.34M | 4.02% | 505 | 856.30K |
| 344 | MENS | Jyong Biotech Ltd. | 161.83M | 0.93% | 17,384 | - |
| 345 | OKUR | OnKure Therapeutics, Inc. | 159.56M | 0.25% | 59,830 | - |
| 346 | OTLK | Outlook Therapeutics, Inc. | 157.56M | -4.30% | 11,497,122 | -1.16M |
| 347 | UNCY | Unicycive Therapeutics, Inc. | 156.83M | 3.30% | 1,013,087 | - |
| 348 | TNYA | Tenaya Therapeutics, Inc. | 156.36M | 0.98% | 1,154,427 | 1.34M |
| 349 | KZIA | Kazia Therapeutics Limited | 153.18M | -1.94% | 148,986 | 1.27M |
| 350 | AARD | Aardvark Therapeutics, Inc. | 149.25M | 15.79% | 173,693 | - |
| 351 | NRXP | NRx Pharmaceuticals, Inc. | 149.20M | 1.42% | 615,302 | 3.39M |
| 352 | MIST | Milestone Pharmaceuticals Inc. | 148.66M | 2.43% | 1,916,948 | 2.34M |
| 353 | CNTB | Connect Biopharma Holdings Limited | 148.62M | 3.51% | 444,927 | 2.95M |
| 354 | SPRB | Spruce Biosciences, Inc. | 148.24M | -0.79% | 62,276 | 697.00K |
| 355 | TLSA | Tiziana Life Sciences Ltd | 147.41M | 1.79% | 832,751 | - |
| 356 | LENZ | LENZ Therapeutics, Inc. | 147.05M | 0.43% | 475,189 | 21.48M |
| 357 | EQ | Equillium, Inc. | 146.47M | 1.76% | 557,292 | 4.39M |
| 358 | PMN | ProMIS Neurosciences, Inc. | 130.12M | -2.68% | 7,171 | - |
| 359 | CBUS | Cibus, Inc. | 129.93M | - | 102,583 | 4.35M |
| 360 | HURA | TuHURA Biosciences, Inc. | 127.45M | -9.91% | 384,942 | - |
| 361 | BDTX | Black Diamond Therapeutics, Inc. | 126.97M | 2.79% | 656,721 | 70.00M |
| 362 | ANIX | Anixa Biosciences, Inc. | 126.23M | 3.34% | 182,425 | - |
| 363 | VANI | Vivani Medical, Inc. | 124.48M | -2.13% | 104,604 | - |
| 364 | GUTS | Fractyl Health, Inc. | 124.16M | 13.85% | 3,390,867 | 3.00K |
| 365 | RANI | Rani Therapeutics Holdings, Inc. | 122.67M | 3.41% | 708,398 | 4.88M |
| 366 | INO | Inovio Pharmaceuticals, Inc. | 122.01M | -2.48% | 5,015,394 | 65.34K |
| 367 | GNLX | Genelux Corporation | 121.89M | -0.73% | 223,719 | 8.00K |
| 368 | NAUT | Nautilus Biotechnology, Inc. | 121.47M | 5.79% | 852,435 | 190.00K |
| 369 | ENGN | enGene Therapeutics Inc. | 119.24M | 0.56% | 242,726 | - |
| 370 | NTHI | NeOnc Technologies Holdings, Inc. | 116.21M | 2.52% | 167,699 | 39.99K |
| 371 | COYA | Coya Therapeutics, Inc. | 114.24M | 0.21% | 70,948 | 8.02M |
| 372 | SEER | Seer, Inc. | 112.41M | 0.50% | 117,096 | 14.22M |
| 373 | ONCY | Oncolytics Biotech Inc. | 107.50M | 5.16% | 545,007 | - |
| 374 | PYPD | PolyPid Ltd. | 103.59M | 0.39% | 169,104 | - |
| 375 | PLYX | Polaryx Therapeutics, Inc. | 103.18M | -3.27% | 108,419 | - |
| 376 | YARW | Yarrow Bioscience, Inc. | 101.99M | -4.65% | 25,965 | - |
| 377 | CUE | Cue Biopharma, Inc. | 100.72M | -2.56% | 177,749 | 37.66M |
| 378 | TENX | Tenax Therapeutics, Inc. | 100.24M | -1.69% | 4,179,567 | - |
| 379 | BMEA | Biomea Fusion, Inc. | 99.30M | 0.74% | 575,160 | - |
| 380 | ACET | Adicet Bio, Inc. | 98.92M | -2.03% | 80,491 | - |
| 381 | KLRS | Kalaris Therapeutics, Inc. | 98.79M | 0.73% | 81,243 | - |
| 382 | PTHS | Pelthos Therapeutics Inc. | 97.66M | -4.31% | 21,635 | 43.30M |
| 383 | ATRA | Atara Biotherapeutics, Inc. | 97.37M | 3.41% | 27,082 | 6.19M |
| 384 | FBIO | Fortress Biotech, Inc. | 95.72M | 3.61% | 202,696 | 68.47M |
| 385 | ACRV | Acrivon Therapeutics, Inc. | 94.71M | 0.45% | 361,233 | - |
| 386 | CGTX | Cognition Therapeutics, Inc. | 94.70M | 4.10% | 308,311 | - |
| 387 | ALDX | Aldeyra Therapeutics, Inc. | 91.70M | 1.33% | 1,098,741 | - |
| 388 | ICCC | ImmuCell Corporation | 91.37M | -0.30% | 11,130 | 30.68M |
| 389 | RLYB | Rallybio Corporation | 89.38M | 1.39% | 6,869 | 646.00K |
| 390 | GANX | Gain Therapeutics, Inc. | 87.51M | 1.26% | 277,459 | - |
| 391 | ELOX | Eloxx Pharmaceuticals, Inc. | 84.66M | 16.27% | 93,064 | - |
| 392 | DWTX | Dogwood Therapeutics, Inc. | 84.64M | 6.87% | 123,377 | - |
| 393 | MAIA | MAIA Biotechnology, Inc. | 84.55M | 0.72% | 379,842 | - |
| 394 | VRCA | Verrica Pharmaceuticals Inc. | 82.80M | -0.82% | 78,820 | 30.32M |
| 395 | OKYO | OKYO Pharma Limited | 80.82M | 1.32% | 14,671 | - |
| 396 | CING | Cingulate Inc. | 80.71M | 4.13% | 234,683 | - |
| 397 | ELTX | Elicio Therapeutics, Inc. | 79.90M | -1.14% | 279,178 | - |
| 398 | TELO | Telomir Pharmaceuticals, Inc. | 77.72M | - | 43,317 | - |
| 399 | ANVS | Annovis Bio, Inc. | 77.54M | 1.68% | 618,556 | - |
| 400 | NRXS | NeurAxis, Inc. | 77.23M | -1.91% | 96,703 | 5.32M |
| 401 | ATHE | Alterity Therapeutics Limited | 76.40M | 4.94% | 10,588 | 4.43M |
| 402 | GOSS | Gossamer Bio, Inc. | 75.62M | -1.78% | 131,355,202 | 53.29M |
| 403 | SER | Serina Therapeutics, Inc. | 72.90M | 8.30% | 46,107 | 130.00K |
| 404 | LONA | LeonaBio, Inc. | 72.19M | -0.19% | 9,649 | - |
| 405 | PLRX | Pliant Therapeutics, Inc. | 71.52M | 3.12% | 504,685 | - |
| 406 | PMVP | PMV Pharmaceuticals, Inc. | 71.10M | 2.31% | 131,307 | - |
| 407 | SPRO | Spero Therapeutics, Inc. | 71.05M | 0.83% | 359,136 | 47.00M |
| 408 | IBIO | iBio, Inc. | 71.04M | -2.72% | 755,205 | 300.00K |
| 409 | OSTX | OS Therapies Incorporated | 70.82M | 0.63% | 386,419 | - |
| 410 | RNTX | Rein Therapeutics Inc. | 70.57M | 3.07% | 583,528 | - |
| 411 | XBIT | XBiotech Inc. | 69.51M | -1.30% | 11,036 | - |
| 412 | CSBR | Champions Oncology, Inc. | 68.91M | -4.25% | 8,155 | 59.43M |
| 413 | CRDF | Cardiff Oncology, Inc. | 68.47M | -3.15% | 653,483 | 508.00K |
| 414 | MNOV | MediciNova, Inc. | 68.42M | 1.46% | 25,959 | 920.48K |
| 415 | BOLD | Boundless Bio, Inc. | 68.24M | 3.45% | 157,158 | - |
| 416 | EXOZ | eXoZymes, Inc. | 66.36M | 1.56% | 10,227 | -700.00 |
| 417 | HYFT | MindWalk Holdings Corp. | 66.25M | 2.92% | 73,445 | 11.43M |
| 418 | INMB | INmune Bio Inc. | 64.39M | 7.41% | 519,819 | 50.00K |
| 419 | BSEM | BioStem Technologies, Inc. | 63.19M | -3.80% | 63,390 | 34.59M |
| 420 | IMA | ImageneBio, Inc. | 62.55M | -1.78% | 19,935 | 800.00K |
| 421 | INKT | MiNK Therapeutics, Inc. | 60.78M | 4.99% | 11,770 | - |
| 422 | XLO | Xilio Therapeutics, Inc. | 60.73M | - | 5,224 | 64.09M |
| 423 | HRTX | Heron Therapeutics, Inc. | 60.41M | 2.98% | 3,015,167 | 151.18M |
| 424 | RNXT | RenovoRx, Inc. | 59.57M | - | 233,270 | 1.98M |
| 425 | NTRB | Nutriband Inc. | 56.72M | 22.32% | 67,532 | 1.80M |
| 426 | IMMP | Immutep Limited | 55.99M | -1.28% | 113,887 | 5.28M |
| 427 | APLM | Apollomics, Inc. | 53.42M | 3.21% | 6,286 | 8.84M |
| 428 | ALPS | Alps Group Inc | 53.25M | 18.52% | 65,120 | 3.74M |
| 429 | TCRX | TScan Therapeutics, Inc. | 52.83M | 0.43% | 136,150 | 7.11M |
| 430 | IBO | Impact BioMedical Inc. | 51.75M | 6.83% | 22,754 | 35.00K |
| 431 | TIL | Instil Bio, Inc. | 51.41M | 2.02% | 9,201 | - |
| 432 | HYPD | Hyperion DeFi, Inc. | 49.42M | 1.27% | 833,431 | 1.40M |
| 433 | ATYR | aTyr Pharma, Inc. | 49.19M | -0.30% | 522,705 | 190.00K |
| 434 | VRXA | Veraxa Biotech AG | 49.17M | 3.17% | 80,058 | - |
| 435 | RNAZ | TransCode Therapeutics, Inc. | 48.59M | -3.37% | 41,410 | - |
| 436 | MGX | Metagenomi Therapeutics, Inc. | 46.47M | 2.50% | 303,193 | 13.56M |
| 437 | FLNA | Filana Therapeutics, Inc. | 46.42M | 1.96% | 107,571 | - |
| 438 | MREO | Mereo BioPharma Group plc | 46.37M | -0.99% | 714,696 | 500.00K |
| 439 | GRCE | Grace Therapeutics, Inc. | 46.28M | 2.80% | 75,904 | - |
| 440 | CNTX | Context Therapeutics Inc. | 45.95M | -3.77% | 1,747,422 | - |
| 441 | MCRB | Seres Therapeutics, Inc. | 45.33M | -0.22% | 45,293 | 1.88M |
| 442 | VERU | Veru Inc. | 45.01M | 2.33% | 177,458 | 16.89M |
| 443 | KPTI | Karyopharm Therapeutics Inc. | 44.46M | 7.69% | 876,794 | 146.62M |
| 444 | EDSA | Edesa Biotech, Inc. | 42.71M | -6.93% | 156,129 | - |
| 445 | HOWL | Werewolf Therapeutics, Inc. | 42.45M | 102.57% | 296,719,377 | 21.00M |
| 446 | ALGS | Aligos Therapeutics, Inc. | 41.65M | 3.57% | 52,329 | 31.52M |
| 447 | CRVO | CervoMed Inc. | 39.61M | 2.34% | 269,568 | 331.30K |
| 448 | BCTX | BriaCell Therapeutics Corp. | 35.13M | 3.56% | 150,427 | - |
| 449 | ATNM | Actinium Pharmaceuticals, Inc. | 34.59M | -1.79% | 144,008 | 35.09M |
| 450 | LITS | Lite Strategy, Inc. | 33.67M | 4.91% | 360,817 | - |
| 451 | QNCX | Quince Therapeutics, Inc. | 33.18M | 5.67% | 9,537 | - |
| 452 | ESLA | Estrella Immunopharma, Inc. | 31.98M | -1.30% | 8,172 | - |
| 453 | IGC | IGC Pharma, Inc. | 31.84M | 11.11% | 1,867,418 | 1.11M |
| 454 | RADX | Radiopharm Theranostics Limited | 31.09M | 6.55% | 48,844 | 10.86M |
| 455 | KYNB | Kyntra Bio, Inc. | 30.45M | 2.73% | 39,965 | 4.62M |
| 456 | ACTU | Actuate Therapeutics, Inc. | 30.39M | 3.25% | 275,822 | - |
| 457 | NNVC | NanoViricides, Inc. | 30.30M | 1.53% | 250,258 | - |
| 458 | LTRN | Lantern Pharma Inc. | 29.91M | 2.18% | 185,081 | - |
| 459 | GNTA | Genenta Science S.p.A. | 29.72M | 5.88% | 28,509 | - |
| 460 | BYSI | BeyondSpring Inc. | 29.61M | - | 59,434 | 1.88M |
| 461 | NXTC | NextCure, Inc. | 28.79M | 0.64% | 36,734 | - |
| 462 | TVGN | Tevogen Inc. | 28.48M | 5.97% | 13,040 | - |
| 463 | QNTM | Quantum BioPharma Ltd. | 27.61M | - | 135,823 | - |
| 464 | EVAX | Evaxion A/S | 27.61M | 0.91% | 540,831 | 7.49M |
| 465 | LGVN | Longeveron Inc. | 26.94M | 2.02% | 770,448 | 1.19M |
| 466 | ENLV | Enlivex Ltd. | 25.70M | -2.00% | 157,528 | - |
| 467 | BRNS | Barinthus Biotherapeutics plc | 25.40M | 1.54% | 11,679 | 14.97M |
| 468 | ATOS | Atossa Therapeutics, Inc. | 25.35M | -1.93% | 25,557 | - |
| 469 | GRDX | GridAI Technologies Corp. | 25.27M | -4.83% | 158,876 | - |
| 470 | NIKI | Niki BioSolutions, Inc. | 25.21M | 4.63% | 30,415 | - |
| 471 | DYAI | Dyadic International, Inc. | 25.14M | -1.43% | 116,130 | 3.80M |
| 472 | CVM | CEL-SCI Corporation | 24.82M | -2.74% | 66,143 | - |
| 473 | TVRD | Tvardi Therapeutics, Inc. | 24.81M | 1.09% | 166,829 | - |
| 474 | CLRB | Cellectar Biosciences, Inc. | 24.48M | - | 26,653 | - |
| 475 | JSPR | Jasper Therapeutics, Inc. | 23.77M | 3.59% | 780,738 | - |
| 476 | MRKR | Marker Therapeutics, Inc. | 23.18M | 13.93% | 99,374 | 2.69M |
| 477 | CELU | Celularity Inc. | 23.16M | 4.31% | 26,345 | 26.55M |
| 478 | ABVC | ABVC BioPharma, Inc. | 23.07M | - | 56,777 | 797.92K |
| 479 | ALLR | Allarity Therapeutics, Inc. | 22.59M | -0.70% | 112,288 | 345.00K |
| 480 | COCP | Cocrystal Pharma, Inc. | 22.15M | -1.71% | 84,747 | 330.00K |
| 481 | NEUP | Neuphoria Therapeutics Inc. | 21.13M | -1.01% | 179,816 | -13.27K |
| 482 | CNSY | Cerenome, Inc. | 21.13M | 2.33% | 106,122 | 4.20M |
| 483 | CALC | CalciMedica, Inc. | 19.56M | -1.78% | 271,556 | - |
| 484 | PLRZ | Polyrizon Ltd. | 19.28M | -1.81% | 23,191 | - |
| 485 | PTN | Palatin Technologies, Inc. | 18.50M | -5.00% | 4,494 | 12.88M |
| 486 | PLUR | Pluri Inc. | 18.45M | -2.26% | 4,605 | 1.08M |
| 487 | LEXX | Lexaria Bioscience Corp. | 18.04M | -3.15% | 8,884 | 194.00K |
| 488 | KTTA | Pasithea Therapeutics Corp. | 18.02M | 14.77% | 302,673 | - |
| 489 | CYCN | Cyclerion Therapeutics, Inc. | 17.92M | -4.42% | 65,692 | 1.90M |
| 490 | NCEL | NewcelX Ltd. | 17.57M | -3.18% | 1,396 | - |
| 491 | LPCN | Lipocine Inc. | 17.23M | - | 18,218 | 1.57M |
| 492 | TPST | Tempest Therapeutics, Inc. | 16.62M | 1.96% | 133,855 | - |
| 493 | PBM | Psyence Biomedical Ltd. | 16.52M | 10.18% | 103,302 | - |
| 494 | CTXR | Citius Pharmaceuticals, Inc. | 16.48M | 0.07% | 160,690 | 7.11M |
| 495 | INTS | Intensity Therapeutics, Inc. | 15.87M | -0.41% | 20,181 | - |
| 496 | KALA | KALA BIO, Inc. | 15.86M | -2.38% | 100,822 | - |
| 497 | HIND | Vyome Holdings, Inc. | 15.79M | -1.32% | 4,688 | 129.73K |
| 498 | CMMB | Chemomab Therapeutics Ltd. | 15.65M | 4.35% | 114,190 | - |
| 499 | BCDA | BioCardia, Inc. | 15.29M | 4.44% | 82,456 | 3.00K |
| 500 | AKTX | Akari Therapeutics, Plc | 15.28M | 0.77% | 10,988 | - |